Drug Profile
Oseltamivir - Hanmi Pharmaceutical
Alternative Names: HGP 0919; HIP-1403Latest Information Update: 23 Dec 2021
Price :
$50
*
At a glance
- Originator Hanmi Pharmaceutical
- Class Acetamides; Antivirals; Cyclohexenes; Esters; Small molecules
- Mechanism of Action Neuraminidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Influenza virus infections
Most Recent Events
- 28 May 2018 No recent reports of development identified for phase-I development in Influenza-virus-infections(In volunteers) in South Korea (PO, Suspension)
- 04 Jan 2017 Chemical structure information added
- 01 Apr 2015 Phase-I clinical trials in Influenza virus infections (In volunteers) in South Korea (PO)